A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects

Posted on December 20, 2017 by hprdsadmin

K. Schaffler, A. Fakhoury, W. He, P. Passier, K. Tracy, J. Paul

in print, Pain Medicine, DOI:10.1093/pm/pnx338

This entry was posted in Clinical Studies. Bookmark the permalink.